寡聚对苯乙炔与多肽拮抗剂RM26的偶联及^(131)I标记研究  

Coupling Reaction of Oligo p-Phenylene Ethynylene and Peptide Antagonist RM26 Labeling with ^(131)I

在线阅读下载全文

作  者:蹇源[1,2] 周志军[2] 卓连刚 赵鹏[2] 廖伟[2] 王关全[2] 刘宁[1] 

机构地区:[1]四川大学原子核科学技术研究所辐射物理及技术教育部国家重点实验室,四川成都610064 [2]中国工程物理研究院,四川绵阳621900

出  处:《同位素》2016年第3期158-163,共6页Journal of Isotopes

基  金:国家自然科学基金项目(21571164)

摘  要:结合寡聚对苯乙炔(oligo p-phenylene ethynylene,OPE)较强细胞膜穿透能力和多肽拮抗剂RM26对PC-3癌细胞的高亲和性,设计合成OPE-RM26偶联物。采用Iodogen涂管法对偶联物进行^(131)I标记,得到标记率为95%的放射性标记物^(131)I-OPE-RM26,室温下放置24h后其放化纯度仍大于90%,具有良好的体外稳定性。研究结果为制备具有靶点识别、膜穿透性、射线杀伤的多功能放射性药物提供参考。Investigations reveale that oligo p-phenylene ethynylene(OPE)molecule can insert into cell membrane,which leads to its cellular internization capacility.Antagonists have high cancer cell affinity,high uptake in cancer cells and fast clearance in normal tissue,these capabilities have attracted much research interest in radiopharmaceutical development.Combining the strong cell-penetrating ability and high affinity of Gastrin-releasing peptide which is overexpressed in the PC-3cells,the thesis designed and synthesized unsymmetric OPE(NH2)molecule.Then the OPE(NH2)molecule was followed by the coupling reaction with RM26 peptide to obtain the OPE-RM26,and(Tyr)3-RM26 was also got for controling study.After that,the(Tyr)3-RM26 and OPE-RM26 were radiolabeled with I-131 to give high radiolabeling yields that could up to 95%.The radiolabeling compound was stable after 24 hstorage at room temperature.These labeled compounds are ready for animal in-vivo experiment.It is expected that OPE-RM26-^131I has multi-properties with targeting membrane crossing fire of radioactive elements.The molecule may fast travel to the target tissue and bind to GRP receptor and internalized into cancer cells.The casade process will give rise to its cancer cell toxicity due to longer retention and more killing effect of ray's irradiation to cancer cells.In this way,OPE-RM26-^131I can achieve better anti-cancer ability.

关 键 词:寡聚对苯乙炔 多肽拮抗剂 偶联反应 ^131I标记 

分 类 号:TL923[核科学技术—核燃料循环与材料]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象